United States Diagnostic Imaging Market

United States Diagnostic Imaging Market Size and Share:

The United States diagnostic imaging market size was valued at USD 8.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 14.1 Billion by 2033, exhibiting a CAGR of 6.2% from 2025-2033. The market is growing due to immense technological advances, the increasing geriatric population in the country, the rising prevalence of chronic diseases, an increase in diagnostic centers, and a favorably favorable reimbursement policy.

The United States diagnostic imaging market is impelled by advancements in medical imaging technology and the overall increasing incidence of chronic diseases. The state-of-the-art equipment, whether resonance imaging (MRI), computed tomography (CT) scans, or ultrasound systems, improve diagnosing and enables early interventions into the disease. These technologies are crucial not only in oncology, cardiologist, and neuroscientist disciplines but also affect patient outcomes if intervention in a timely manner is presented. The escalating demand in the market for minimally invasive diagnostic procedures and accurate diagnosis with minimal risk and discomfort from both the patient's and the providers' ends are providing an impetus to the market growth.

Concurrent with this, studies reveal that the number of Americans ages 65 and older is expected to grow to 82 million by 2050, a 47% growth, and the share of total population aged 65 and older is likely to increase from 17% to 23%. Hence, the boom in the market is seen because this expanding population of older people requires many imaging services for age-related problems, such as arthritis, osteoporosis, and heart ailments. Also, the growing number of people understanding the importance of getting periodical health checks and diagnostic tests is resulting in a greater demand for diagnostic imaging across the country. The government's support promoting health through infrastructural development and offering covers for people getting various imaging services is aiding in market expansion.

United States Diagnostic Imaging Market Trends:

Technological Advancements

The U.S. diagnostic imaging market is significantly driven by ongoing technological advancements. Innovations in imaging technologies such as MRI, CT, and ultrasound are continuously improving diagnostic capabilities, accuracy, and patient safety. High-resolution imaging equipment now offers greater precision in detecting complex diseases at earlier stages, which facilitates timely treatment planning. AI incorporation into imaging technologies enables automated picture analysis, which speeds up diagnosis and reduces human error. Hybrid imaging systems, with their increased usage in conjunction with functional and anatomical data for full assessments, are more prevalent. Advances in portable and miniaturized imaging devices have opened up avenues for diagnostic imaging beyond hospital campuses and made better accessibility of the facilities available to the patients. All these advances have meant greater usage in healthcare delivery facilities and led to improvement in patient care, resulting in growth for the market.

Rising Geriatric Population

The growing geriatric population in the U.S. is one of the major driving factors for the diagnostic imaging market. With age, people become more prone to chronic diseases such as cancer, osteoporosis, and cardiovascular disease, which demand frequent imaging for monitoring and diagnosis. As of 2023, about 24.3% of U.S. adults aged 65 and older reported being in fair or poor health. Hypertension is common among this population, with rates increasing to 83.2% for men and 84.1% for women aged 75 and older. Detection and management of these problems require diagnostic imaging, thus guiding clinicians toward appropriate decisions in managing their patients' care. Other areas that drive investments in imaging infrastructure and technology are rising demands related to age.

Prevalence of Chronic Diseases

The growing number of chronic diseases in the U.S. is another crucial reason for the rise in the diagnostic imaging market. According to industry reports, around 129 million people in the country have at least one major chronic disease, and about 42% of them have two or more. Cancer, diabetes, and heart issues need really detailed imaging so doctors can diagnose accurately, keep track of things over time, and plan the right treatment. As chronic diseases are also responsible for a significant amount of expenditure in healthcare, dependency on these imaging technologies is ever-growing, including CT, MRI, and nuclear medicine. In addition to this, the early detection of diseases becomes possible through advanced imaging, but it also boosts targeted strategies for treatment that enhance patient survival. The consistent rise in chronic disease cases has encouraged healthcare facilities to upgrade their imaging capabilities and expand their diagnostic services.

United States Diagnostic Imaging Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the United States diagnostic imaging market, along with forecasts at the country and regional levels from 2025-2033. The market has been categorized based on modality, application, end user, and region.

Analysis by Modality:

• MRI 
  • Low and Mid Field MRI Systems
  • High Field MRI Systems
  • Very High and Ultra High Field MRI Systems
• Computed Tomography 
  • Low-End Scanners
  • Mid-Range Scanners
  • High-End Scanners
• Ultrasound 
  • 2D Ultrasound
  • 3D Ultrasound
  • Others
• X-Ray 
  • Analog Systems
  • Digital Systems
• Nuclear Imaging 
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
• Others
   

MRI is valued highly for its exceptional ability to outline delicate detail and assess soft tissues, including those in the brain, spinal cord, joints, and even inner organs.

CT imaging is of significant importance because it can provide detailed cross-sectional images that help in diagnosing a wide range of conditions, from trauma to cancer and cardiovascular diseases. This capability is particularly valuable in emergency medicine, where rapid diagnosis is critical.

Ultrasound imaging has become very popular due to its excellent versatility and lack of invasiveness, now commonly used in obstetrics, cardiology, and for abdominal examinations. The advancements also make it accessible in outpatient and home settings.

X-ray imaging is one among the most common modalities used in diagnosing bone fracture, chest conditions, and various dental issues. Digital radiography has improved the overall quality of images taken and reduced radiation doses, making patients safer. Even quick image sharing and integration with EMRs help streamline clinical work through digital radiography.

Nuclear imaging, including PET and SPECT scans, essentially deals with checking the condition of different organs and spotting early signs of diseases like cancer and heart disease. In recent years, advances in radiopharmaceuticals and hybrid imaging systems have really taken diagnostic accuracy to a whole new level and opened up new avenues for nuclear imaging.

Analysis by Application:

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Others
   

Cardiology employs different techniques, such as echocardiography, cardiac MRI, and CT angiography, to study the anatomy of the heart, how it functions, and the flow of blood. Techniques like 3D echocardiography and cardiac PET scans have been employed in order to better diagnose and detect diseases such as coronary artery disease and problems with the heart valves earlier.

Oncology relies on advanced technologies like PET, CT, and MRI for tumor identification, staging, and treatment response monitoring. In conditions concerning the brain and spinal cord, MRI provides the most suitable imaging mode for highly detailed imaging for a variety of disorders including multiple sclerosis, brain tumors, and stroke.

Neuroradiology applications play an essential proportion of the U.S. market for diagnostic imaging. Although for conditions impacting the brain and spinal cord, MRI still tends to be the preferred choice. For high-resolution image generation, MRI is, therefore a highly valuable diagnosis tool, especially for diseases including multiple sclerosis, brain tumor, and stroke.

Orthopedic imaging diagnoses diseases and conditions of the musculoskeletal system. Standard initial diagnosis involves taking X-rays. MRI and CT scans are used in detail when the case involves problems with soft tissue and the structure of bone.

In gastroenterology, techniques like ultrasound, CT, and MRI are used to diagnose liver disease, pancreatic tumors, and inflammatory bowel conditions. Endoscopic ultrasound (EUS) combines endoscopy and ultrasound to provide detailed images of the gastrointestinal tract and surrounding organs. 

Gynecological imaging plays a vital role in the diagnosis and monitoring of diseases associated with the female reproductive system. Advances in 3D and 4D ultrasound have helped enhance fetal assessments and earlier detection of abnormalities.

Analysis by End User:

• Hospitals
• Diagnostic Centers
• Others
   

Hospitals account for a significant share of the U.S. diagnostic imaging market as the major providers of care, offering all services under one roof. Healthcare centers usually have MRI, CT, or PET scanners as high-tech equipment available for detecting various diseases.

On the other hand, the diagnostic center segment is another fast-emerging sector of the U.S. diagnostic imaging market that provides specialty, usually outpatient, imaging services. This focuses on speed, cost effectiveness, and convenience in reaching diagnostic facilities outside hospitals, thus an attractive avenue for patients in search of hospital-free diagnostics. Independent and chain diagnostic centers are proliferating the expansion of advanced imaging technology like digital X-ray, ultrasound, MRI, and CT scans.

Regional Analysis:

• Northeast
• Midwest
• South
• West
   

The diagnostic imaging scenario in the Northeast U.S. is impressive, with its large number of advanced medical facilities and academic hospitals. There are numerous top healthcare institutions and research centers in this area. Also, given the number of residents in the region and the aging population, there is a surging demand for diagnostic imaging services with respect to cardiology and oncology, among other specialties.

The diagnostic imaging market in the U.S. Midwest is growing significantly due to its network of community hospitals, clinics, and specialty centers. Although it has a mix of cities and countryside, there is also a push for better healthcare services, such as advanced imaging technology.

The diagnostic imaging market down South is bolstering because of its growing population dealing with chronic issues like heart disease and diabetes. Big cities like New York and surrounding suburbs make up the states in that area and drive significant demand for diagnostic imaging in this region.

The Western U.S. is a tech hub and focuses on forward-thinking healthcare practices. The tech-savvy population of this area is increasingly demanding advanced and novel technologies like AI-integrated imaging and portable devices, which is positively impacting the market growth.

Competitive Landscape:

Top firms in the U.S. diagnostic imaging market are strongly exploring several measures to help preserve and build their existing positions. Companies are focusing on technological developments, like AI and ML, which may assist in more accurate interpretation and enhanced quality of images. Additionally, collaborative efforts are being implemented with alliances and partnerships to advance their service portfolio and blend end-to-end healthcare provision solutions. Companies are also focusing their merger and acquisition efforts on strengthening their geographic presence to reach an ever-increasing patient pool. Moreover, there is a trend of developing portable and point-of-care (POC) imaging devices to increase accessibility in even more underserved areas.

The report provides a comprehensive analysis of the competitive landscape in the United States diagnostic imaging market with detailed profiles of all major companies.

Latest News and Developments:

• In May 2024: United Imaging, a leader in manufacturing advanced medical imaging and radiotherapy equipment, received US Food and Drug Administration (FDA) clearance for its uMR Jupiter 5T magnetic resonance imaging (MRI) system. It is the first ultra-high field system cleared for whole body applications.
• In November 2024: Technology leader Royal Philips received US Food and Drug Administration (FDA)'s 510(k) clearance of its new detector-based Spectral CT 7500 RT, a radiotherapy solution within computed tomography (CT) spectral computed tomography.

United States Diagnostic Imaging Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States diagnostic imaging market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the United States diagnostic imaging market.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States diagnostic imaging industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.